Hostname: page-component-7c8c6479df-fqc5m Total loading time: 0 Render date: 2024-03-29T06:52:26.569Z Has data issue: false hasContentIssue false

Abundant sunshine and vitamin D deficiency

Published online by Cambridge University Press:  01 June 2008

Inez Schoenmakers
Affiliation:
MRC Human Nutrition Research, Elsie Widdowson Laboratory, Fulbourn Road, CambridgeCB1 9NL, UK MRC, Keneba, The Gambia email inez.schoenmakers@mrc-hnr.cam.ac.uk
Gail R. Goldberg
Affiliation:
MRC Human Nutrition Research, Elsie Widdowson Laboratory, Fulbourn Road, CambridgeCB1 9NL, UK MRC, Keneba, The Gambia email inez.schoenmakers@mrc-hnr.cam.ac.uk
Ann Prentice
Affiliation:
MRC Human Nutrition Research, Elsie Widdowson Laboratory, Fulbourn Road, CambridgeCB1 9NL, UK MRC, Keneba, The Gambia email inez.schoenmakers@mrc-hnr.cam.ac.uk
Rights & Permissions [Opens in a new window]

Abstract

Type
Invited Commentary
Copyright
Copyright © The Authors 2008

In this issue of the British Journal of Nutrition, Islam et al. (Reference Islam, Shamim, Kemi, Nevanlinna, Akhtaruzzaman, Laaksonen, Jehan, Jehan, Khan and Lamberg-Allardt1) and Woo et al. (Reference Woo, Lam and Leung2) present data from Bangladesh and China showing a high prevalence of poor vitamin D status in women of childbearing age combined with a concurrent elevation in plasma parathyroid hormone (PTH) concentration. These reports add to the growing evidence of a high prevalence of vitamin D insufficiency in countries with abundant sunshine(Reference Fraser3Reference Prentice5).

Vitamin D can be acquired by cutaneous synthesis following exposure to sunlight and from the diet(Reference Fraser3Reference Prentice5). Vitamin D supply varies considerably worldwide, across population groups and between individuals, mainly because of differences in skin exposure to UVB radiation, the efficiency of cutaneous synthesis (for example, due to ageing and skin pigmentation) and in food fortification practices and supplement use(Reference Fraser3, Reference Lips4).

Vitamin D is an important determinant of bone health at all ages; deficiency causes rickets in children and osteomalacia in children and adults. A low vitamin D status has also been associated with increased bone loss and osteoporotic fracture risk in older people(6, 7).

Markers of vitamin D status

Vitamin D is hydroxylated in the liver to 25-hydroxyvitamin D (25OHD). This circulates in plasma and serves as a reservoir for further hydroxylation to the biologically active metabolite 1,25-dihydroxyvitamin D. The plasma concentration of 25OHD is the most commonly used biomarker of vitamin D status because it has a long half-life and because it is not under tight homeostatic regulation and therefore reflects vitamin D supply and usage over a period of time(Reference Horst, Reinhardt, Reddy, Feldman, Pike and Glorieux8).

In the UK, a threshold concentration of 25 nmol/l (10 ng/ml) has traditionally been used to define a level above which there is little risk of vitamin D-deficiency rickets or osteomalacia(6, 7). More recently, links between vitamin D status and other health outcomes (for example, osteoporosis, cancer, CVD, diabetes, tuberculosis) have led to debates about what defines vitamin D sufficiency across the lifecycle and in different population groups(Reference Prentice5, Reference Bischoff-Ferrari, Giovannucci, Willett, Dietrich and Dawson-Hughes9). Proposed lower thresholds of 25OHD concentration range between 50 and 100 nmol/l(Reference Prentice5, Reference Norman, Bouillon, Whiting, Vieth and Lips10). A complication in this debate is the lack of methodological standardisation of 25OHD measurements(Reference Binkley, Drezner and Hollis11). Participation in the Vitamin D External Quality Assessment Scheme (www.deqas.org) helps to monitor assay and laboratory performance but it is not yet common practice to report these data in publications.

PTH has been proposed as a functional marker of vitamin D status because it is linked to 25OHD through the Ca–phosphate homeostatic system. An inverse relationship between the plasma concentrations of PTH and 25OHD has been reported in many cross-sectional and intervention studies(Reference Bates, Carter, Mishra, O'Shea, Jones and Prentice12Reference Malabanan, Veronikis and Holick15) and an elevated plasma PTH concentration is considered to be a risk factor for osteoporosis(Reference Hodsman, Hanley, Watson, Fraher, Bilezikian, Raisz and Rodan14, Reference Malabanan, Veronikis and Holick15). However, most studies have been conducted among older Caucasian people in Europe and the USA(Reference Bates, Carter, Mishra, O'Shea, Jones and Prentice12Reference Malabanan, Veronikis and Holick15) and PTH is influenced by many factors other than vitamin D status, including stage of life, ethnic background, dietary Ca and phosphate intake, time of day and assay method(Reference Chapuy, Preziosi, Maamer, Arnaud, Galan, Hercberg and Meunier13, Reference Vieth, Ladak and Walfish16Reference Souberbielle, Cormier, Kindermans, Gao, Cantor, Forette and Baulieu18). Our studies in The Gambia and China, for example, have shown that plasma PTH concentration is elevated in populations with a low Ca intake, even when vitamin D status is good, and that the inverse correlations between plasma PTH concentration and bone health indices observed in Western countries are not found(Reference Prentice5, Reference Yan, Zhou, Wang, D'Ath, Laidlaw, Laskey and Prentice19, Reference Aspray, Yan and Prentice20).

In older Caucasian populations bone mineral density (BMD) is a useful marker of fracture risk (www.ISCD.org), and has been used as a functional outcome measure in vitamin D studies. However, the use of BMD measures to predict fracture risk does not necessarily apply to younger people or non-Caucasians(Reference Prentice21).

Therefore as we have recently argued, it is unlikely that a single biomarker of vitamin D status, threshold value of 25OHD concentration or outcome measure of vitamin D deficiency will be identified for use in all situations, and research is needed to refine existing biomarkers or to establish new indicators(Reference Prentice, Goldberg and Schoenmakers17).

Cutaneous and dietary supply of vitamin D

In general people derive most of their vitamin D via exposure to sunlight, and official recommendations for vitamin D intake with respect to bone health are based on this assumption. Hence in the UK, for example, reference nutritional intakes are only set for stages of life where requirements are high (infants and children, pregnant and lactating women, older people), and those in vulnerable groups whose sun exposure might be limited(6, 22).

Endogenous vitamin D production requires skin exposure to UVB radiation of wavelengths 290–315 nm, which can occur all year at tropical latitudes and in the summer months at temperate latitudes(Reference Diffey23) (http://nadir.nilu.no/~olaeng/fastrt/VitaminD.html). It is not surprising therefore that in people living at temperate latitudes, for example, UK (50–62°N) and Beijing (39°N), there can be marked seasonal variation in plasma 25OHD concentration, i.e. lower in winter v. summer months, and that the contribution of dietary sources to vitamin D status is greatest during the winter(Reference Woo, Lam and Leung2, Reference Bates, Carter, Mishra, O'Shea, Jones and Prentice12, Reference Yan, Prentice, Zhang, Wang, Stirling and Golden24). What may come as a surprise is that in countries where theoretically vitamin D synthesis can occur all year round, there are reports of a high prevalence of low vitamin D status. The studies by Islam et al. (Reference Islam, Shamim, Kemi, Nevanlinna, Akhtaruzzaman, Laaksonen, Jehan, Jehan, Khan and Lamberg-Allardt1) in Dhaka (23°N) and Woo et al. (Reference Woo, Lam and Leung2) in Hong Kong (22°N) illustrate the many factors that can limit cutaneous vitamin D synthesis, including environmental conditions such as pollution, time spent indoors because of living and working conditions, customary dress because of weather, culture and religion, skin pigmentation and use of sunscreen(Reference Prentice5). Woo et al. (Reference Woo, Lam and Leung2) commented that 60 % of women in Hong Kong indicated they did not like going out in the sun. Islam et al. (Reference Islam, Shamim, Kemi, Nevanlinna, Akhtaruzzaman, Laaksonen, Jehan, Jehan, Khan and Lamberg-Allardt1) reported that >90 % of their subjects used sunscreen.

Vitamin D deficiency: a global perspective

Although different methodologies were used, the studies by Woo et al. (Reference Woo, Lam and Leung2) and Islam et al. (Reference Islam, Shamim, Kemi, Nevanlinna, Akhtaruzzaman, Laaksonen, Jehan, Jehan, Khan and Lamberg-Allardt1) both report a high number of women with values of 25OHD < 25 nmol/l (16 % in Dhaka; 18 % in Hong Kong and 40 % in Beijing, measured in the spring time) and that >90 % of women had 25OHD < 50 nmol/l(Reference Islam, Shamim, Kemi, Nevanlinna, Akhtaruzzaman, Laaksonen, Jehan, Jehan, Khan and Lamberg-Allardt1, Reference Woo, Lam and Leung2). This is of concern because of potential adverse consequences for the women's own health and because poor vitamin D status in pregnant women is associated with decreased fetal and childhood bone mineral accretion, and an increased risk of rickets in their infants(Reference Fraser3, Reference Cooper, Javaid, Westlake, Harvey and Dennison25, Reference Javaid, Crozier, Harvey, Gale, Dennison, Boucher, Arden, Godfrey and Cooper26). Furthermore, poor vitamin D status in women of childbearing age indicates that status is also likely to be poor in other age groups in the population. Based on the presence of rickets or a plasma 25OHD concentration < 25 nmol/l, current evidence shows that the prevalence of vitamin D deficiency is high in many parts of the world, for example, among elderly people in the UK, especially those living in residential care, among infants and pregnant women from ethnic minorities at northerly and southerly latitudes, in people living in or near the tropics who wear concealing clothing or who spend little time out of doors, those with a low Ca intake and among children from Asia and the Middle East(Reference Fraser3Reference Prentice5, Reference Bates, Carter, Mishra, O'Shea, Jones and Prentice12).

Emerging research is leading to a substantial body of evidence on vitamin D and prevention or reduction of chronic and infectious diseases(6). This in turn is leading to calls to redefine deficiency and increase recommendations for intake. At the same time, frank vitamin D deficiency is a major public health problem in many parts of the world that requires urgent attention(Reference Prentice5). It is important that policy solutions including the promotion of safe (with respect to melanoma risk) and culturally acceptable skin exposure to UVB sunlight, and supplementation strategies where appropriate are found to address this burden of deficiency. Action should not be delayed by the current scientific debate about thresholds of 25OHD and optimal function and health(Reference Prentice5).

None of the authors have any conflicts of interest or sources of funding to report.

References

1Islam, MZ, Shamim, AA, Kemi, V, Nevanlinna, A, Akhtaruzzaman, M, Laaksonen, M, Jehan, AH, Jehan, K, Khan, HU & Lamberg-Allardt, C (2008) Vitamin D deficiency and low bone status in adult female garment workers in Bangladesh. Br J Nutr 99, 13221329.CrossRefGoogle ScholarPubMed
2Woo, J, Lam, CWK, Leung, J, et al. (2008) Very high rates of vitamin D insufficiency in women of child-bearing age living in Beijing and Hong Kong. Br J Nutr 99, 13301334.CrossRefGoogle ScholarPubMed
3Fraser, DR (2004) Vitamin D-deficiency in Asia. J Steroid Biochem Mol Biol 89–90, 491495.Google Scholar
4Lips, P (2007) Vitamin D status and nutrition in Europe and Asia. J Steroid Biochem Mol Biol 103, 620625.CrossRefGoogle ScholarPubMed
5Prentice, A (2008) Vitamin D deficiency: a global perspective Nutr Rev (In the Press)..CrossRefGoogle ScholarPubMed
6The Scientific Advisory Committee on Nutrition (2007) Update on Vitamin D. London: The Stationery Office.Google Scholar
7Department of Health (1998) Nutrition and Bone Health: With Particular Reference to Calcium and Vitamin D. London: The Stationery Office.Google Scholar
8Horst, RL, Reinhardt, TA & Reddy, GS (2005) Vitamin D metabolism. In Vitamin D, 2nd ed., pp. 1536 [Feldman, D, Pike, JW and Glorieux, FH, editors]. Burlington, MA: Elsevier Academic Press.Google Scholar
9Bischoff-Ferrari, HA, Giovannucci, E, Willett, WC, Dietrich, T & Dawson-Hughes, B (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84, 1828.CrossRefGoogle ScholarPubMed
10Norman, AW, Bouillon, R, Whiting, SJ, Vieth, R & Lips, P (2007) 13th Workshop consensus for vitamin D nutritional guidelines. J Steroid Biochem Mol Biol 103, 204205.Google Scholar
11Binkley, N, Drezner, MK & Hollis, BW (2006) Laboratory reporting of 25-hydroxyvitamin D results: potential for clinical misinterpretation. Clin Chem 52, 21242125.CrossRefGoogle ScholarPubMed
12Bates, CJ, Carter, GD, Mishra, GD, O'Shea, D, Jones, J & Prentice, A (2003) In a population study, can parathyroid hormone aid the definition of adequate vitamin D status? A study of people aged 65 years and over from the British National Diet and Nutrition Survey. Osteoporos Int 14, 152159.CrossRefGoogle Scholar
13Chapuy, MC, Preziosi, P, Maamer, M, Arnaud, S, Galan, P, Hercberg, S & Meunier, PJ (1997) Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7, 439443.CrossRefGoogle Scholar
14Hodsman, AB, Hanley, DA, Watson, PH & Fraher, LJ (2002) Parathyroid hormone. In Principles of Bone Biology, pp. 13051324 [Bilezikian, JP, Raisz, LG and Rodan, GA, editors]. New York: Academic Press.CrossRefGoogle Scholar
15Malabanan, A, Veronikis, IE & Holick, MF (1998) Redefining vitamin D insufficiency. Lancet 351, 805806.CrossRefGoogle ScholarPubMed
16Vieth, R, Ladak, Y & Walfish, PG (2003) Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J Clin Endocrinol Metab 88, 185191.CrossRefGoogle ScholarPubMed
17Prentice, A, Goldberg, GR & Schoenmakers, I (2008) Vitamin D across the life cycle: physiology and biomarkers Am J Clin Nutr (In the Press)..CrossRefGoogle ScholarPubMed
18Souberbielle, JC, Cormier, C, Kindermans, C, Gao, P, Cantor, T, Forette, F & Baulieu, EE (2001) Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. J Clin Endocrinol Metab 86, 30863090.Google Scholar
19Yan, L, Zhou, B, Wang, X, D'Ath, S, Laidlaw, A, Laskey, MA & Prentice, A (2003) Older people in China and the United Kingdom differ in the relationships among parathyroid hormone, vitamin D, and bone mineral status. Bone 33, 620627.Google Scholar
20Aspray, TJ, Yan, L & Prentice, A (2005) Parathyroid hormone and rates of bone formation are raised in perimenopausal rural Gambian women. Bone 36, 710720.CrossRefGoogle ScholarPubMed
21Prentice, A (2004) Diet, nutrition and the prevention of osteoporosis. Public Health Nutr 7, 227243.CrossRefGoogle ScholarPubMed
22Institute of Medicine, Food and Nutrition Board (1997) Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride. Washington, DC: National Academic Press.Google Scholar
23Diffey, BL (2002) Sources and measurement of ultraviolet radiation. Methods 28, 413.CrossRefGoogle ScholarPubMed
24Yan, L, Prentice, A, Zhang, H, Wang, X, Stirling, DM & Golden, MM (2000) Vitamin D status and parathyroid hormone concentrations in Chinese women and men from north-east of the People's Republic of China. Eur J Clin Nutr 54, 6872.CrossRefGoogle ScholarPubMed
25Cooper, C, Javaid, K, Westlake, S, Harvey, N & Dennison, E (2005) Developmental origins of osteoporotic fracture: the role of maternal vitamin D insufficiency. J Nutr 135, 2728S2734S.CrossRefGoogle ScholarPubMed
26Javaid, MK, Crozier, SR, Harvey, NC, Gale, CR, Dennison, EM, Boucher, BJ, Arden, NK, Godfrey, KM & Cooper, C; Princess Anne Hospital Study Group (2006) Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet 367, 3643.CrossRefGoogle ScholarPubMed